CTRI/2024/02/063138
Not yet recruiting
Phase 3
Comparison of efficacy and safety of intralesional triamcinolone acetonide at different strength in treatment of alopecia areata: A Randomized Controlled Trial. - NI
Institute of Medical Sciences BH0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Sponsor
- Institute of Medical Sciences BH
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. All clinically diagnosed cases of alopecia areata with duration of illness more than 4 months.
Exclusion Criteria
- •1\. Patients with existing skin diseases affecting the scalp such as psoriasis or seborrheic dermatitis.
- •2\. Patients with evidence of adrenal cortex abnormality.
- •3\. Patients known to be HIV or hepatitis B, C positive or otherwise immunocompromised
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A clinical trial to study the effects of drug named Triamcinolone alone or combination of Triamcinolone and 5- Fluorouracil in patients with Keloid or hypertrophic scarsACTRN12612000546853Farrukh Aslam Khalid120
Recruiting
Not Applicable
Treatment of common wartsCTRI/2017/07/009028il50
Completed
Phase 2
Comparison of tranexamic acid versus Kligman’s application in the treatment of macular amyloidosisIRCT20150529022468N5Iran University of Medical Sciences40
Completed
Not Applicable
To compare efficacy of treatment by intralesional bleomycin and intralesional vitamin D-3 in common warts.CTRI/2021/04/032610Department of Dermatology Venereology and Leprosy32
Not yet recruiting
Not Applicable
Comparative therapeutic efficacy of Intralesional corticosteroid injection alone versus combination of Cryotherapy and Intralesional corticosteroid injection in AA: a randomised split scalp studyHealth Condition 1: L639- Alopecia areata, unspecifiedCTRI/2022/11/047768Garima Manocha